Skip to content

Impact of Systematic Shaving on Margins

Reduction of Affected Margins in Conservative Surgery for Breast Cancer: Impact of Systematic Shaving in the Operating Room

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05782686
Enrollment
234
Registered
2023-03-23
Start date
2020-10-07
Completion date
2027-10-16
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Margin, Tumor-Free, Surgery

Brief summary

The objective of this clinical trial is to demonstrate the reduction of positive margins in the definitive pathology of patients undergoing breast-conserving surgery with the systematic shaving technique compared to conventional surgery, and the reduction of second interventions for margin enlargement.

Detailed description

Patients with breast cancer who undergo breast-conserving surgery are randomized in the operating room after lumpectomy into 2 groups of 117 patients each: shaving/no-shaving (standard surgery).

Interventions

PROCEDUREMargin shaving

In both cohorts, an intraoperative study of the margins will be carried out, and enlargement of those margins that are affected will be carried out as indicated by the pathologist. Subsequently, shaving is performed in case of being randomized to the study group or surgery is completed in the control group.

Sponsors

Hospital Universitari de Bellvitge
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Randomization will be performed by another investigator outside the operating room after lumpectomy.

Intervention model description

Randomized clinical trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Breast-conserving surgery. 2. Imaging diagnosis as the only breast tumor focus according to mammography, breast ultrasound and/or nuclear magnetic resonance; 3. Pathological diagnosis of carcinoma in situ or infiltrating 4. Oncoplastic without associated flaps;

Exclusion criteria

1. Male patients; 2. Patients with a history of ipsilateral breast cancer. 3. Oncoplastic that includes flaps 4. Multifocality or multicentricity; 5. Pregnant or lactating patient; 6. Stage IV patients; 7. Patients eligible for mastectomy;

Design outcomes

Primary

MeasureTime frameDescription
Margin involvement3 weeks after each surgeryTo compare the number of cases with affected margins in the definitive pathological anatomy, of the cases with intraoperative systematic shaving versus the group of no shaving
Re-interventions3 weeks after each surgeryDemonstrate the reduction of second surgeries to widen affected margins in breast conserving surgery with the shaving technique

Secondary

MeasureTime frameDescription
Shaving versus intraoperative pathological study3 weeks after each surgeryAssess the possibility of replacing the intraoperative study of the margins with systematic shaving

Countries

Spain

Contacts

CONTACTamparo garcia-tejedor, MDPhD
agarciat@bellvitgehospital.cat932607695
PRINCIPAL_INVESTIGATORAmparo Garcia Tejedor, MDPhD

Hospital de Bellvitge. Instituto de Investigación Biomédica de Bellvitge (IDIBELL)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026